Serum alkaline phosphatase and infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-cohort study
Serum alkaline phosphatase and infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-cohort study
复制标题
血液透析患者的血清碱性磷酸酶和感染相关死亡率:Q 队列研究的十年结果
DOI:
10.1007/s10157-022-02255-4
复制
发表时间:
2022
影响因子:
2.3
通讯作者:
Kitazono Takanari
中科院分区:
文献类型:
--
作者:
Kitamura Hiromasa;Yotsueda Ryusuke;Hiyamuta Hiroto;Taniguchi Masatomo;Tanaka Shigeru;Yamada Shunsuke;Tsuruya Kazuhiko;Nakano Toshiaki;Kitazono Takanari
BackgroundHigh serum alkaline phosphatase (ALP) levels are associated with excess all-cause and cardiovascular mortality in patients undergoing hemodialysis (HD). However, the long-term relationship between serum ALP levels and infection-related mortality remains unclear.MethodsA total of 3502 maintenance HD patients were registered in the Q-Cohort Study, an observational cohort study in Japan. The primary outcome was infection-related mortality during a 10-year follow-up period. The covariate of interest was serum ALP levels at baseline. The association between serum ALP levels and infection-related mortality was calculated using a Cox proportional hazards model and a Fine–Gray subdistribution hazards model with non-infection-related death as a competing risk.ResultsDuring the follow-up period, 446 patients died of infection. According to their baseline serum ALP levels, the patients were categorized into sex-specific quartiles (Q1–Q4). Compared with patients in the lowest serum ALP quartile (Q1), those in the highest quartile (Q4) had a significantly higher multivariable-adjusted hazard ratio (HR) of 1.70 [95% confidence interval (CI) 1.24–2.32] for infection-related mortality. Furthermore, the HR for every 50 U/L increase in serum ALP levels was 1.24 (95% CI 1.12–1.36) for infection-related mortality. These associations remained consistent in the competing risk model: subdistribution HR, 1.47; 95% CI 1.07–2.03 for Q4 compared with Q1.ConclusionHigher serum ALP levels were significantly associated with a higher risk of infection-related mortality in patients undergoing HD.
登录
查看更多内容
DOI:
10.2215/cjn.11501210
发表时间:
2011-09-01
影响因子:
9.8
作者:
Akizawa, Tadao;Kido, Ryo;Kurokawa, Kiyoshi
通讯作者:
Kurokawa, Kiyoshi
DOI:
10.1016/0009-8981(77)90042-0
发表时间:
1977
期刊:
Clinica chimica acta; international journal of clinical chemistry
影响因子:
--
作者:
A. Skillen;A. Pierides
通讯作者:
A. Pierides
影响因子:
3.4
作者:
Eriguchi, Rieko;Taniguchi, Masatomo;Kitazono, Takanari
通讯作者:
Kitazono, Takanari
DOI:
--
发表时间:
2016
期刊:
Rinsho byori. The Japanese journal of clinical pathology
影响因子:
--
作者:
S. Yamadate;T. Nakayama
通讯作者:
T. Nakayama
影响因子:
2.3
作者:
Hiyamuta, Hiroto;Yamada, Shunsuke;Kitazono, Takanari
通讯作者:
Kitazono, Takanari